Global Cytomegalovirus Retinitis Impact of Drivers and Challenges 2018

1
Global Cytomegalovirus Retinitis Market 2014-2018
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published August 2014
• Single User PDF US 2500
• Corporate User PDF US 3500

2
Global Cytomegalovirus Retinitis Market 2014-2018

• An increase in combination therapies for the
  treatment of cytomegalovirus retinitis is a major
  trend emerging in the market. These therapies
  lower drug resistance in patients and ensure more
  effective action of the drug.
• Cytomegalovirus retinitis is a viral eye
  inflammation of the retina. The causative
  organism of this disease is cytomegalovirus, a
  herpes virus that attacks the photosensitive
  cells in the retina. This disease can lead to
  permanent blindness if left untreated. It affects
  one eye initially but spreads to the other eye if
  neglected. The virus is very commonly found in
  humans but stays dormant. It usually affects a
  person with weakened immune system such as
  HIV-positive patients. There are two forms of
  cytomegalovirus retinitis indolent form and
  fulminant form. Some of the common symptoms of
  cytomegalovirus retinitis are blurred vision,
  seeing floaters, photophobia, and blind spots.
• Analysts forecast the Global Cytomegalovirus
  Retinitis market to grow at a CAGR of 4.50
  percent over the period 2013-2018. According to
  the report, the Global Cytomegalovirus Retinitis
  market is experiencing a large number of unmet
  needs. Currently, Roche's Valcyte is the only
  branded drug available for the treatment of this
  indication. The market has also observed the use
  of off-label drugs for the treatment of
  cytomegalovirus retinitis.
• Single User License Available at US 2500 Order a
  copy of this report at _at_ http//www.reportsnreport
  s.com/Purchase.aspx?name295209.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Global Cytomegalovirus Retinitis Market 2014-2018

• Covered in this Report
• This report covers the present scenario and the
  growth prospects of the Global Cytomegalovirus
  Retinitis market for the period 2014-2018. To
  calculate the market size, the report considers
  the revenue generated from the sales of various
  branded and generic drugs used for the treatment
  of cytomegalovirus retinitis. Capsules, implants,
  solutions, and tablets are the four dosage forms
  of the drugs used for the treatment of
  cytomegalovirus retinitis.
• Global Cytomegalovirus Retinitis market
  2014-2018, has been prepared based on an in-depth
  market analysis with inputs from industry
  experts. The report covers the Americas, and the
  EMEA and APAC regions it also covers the Global
  Cytomegalovirus Retinitis market landscape and
  its growth prospects in the coming years. The
  report includes a discussion of the key vendors
  operating in this market.
• Further, the report states that one of the major
  challenges in the market is a lack of approved
  treatment guidelines by the WHO, which is
  responsible for the negligence of the treatment
  of cytomegalovirus retinitis worldwide.
• Inquiry Before Buying on this Report _at_
  http//www.reportsnreports.com/contacts/InquiryBef
  oreBuy.aspx?name295209.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Global Cytomegalovirus Retinitis Market 2014-2018

• Key Regions
• Americas
• APAC
• EMEA
• Key Vendors
• F. Hoffmann-La Roche
• Gilead Sciences
• Hospira
• Shire
• Other Prominent Vendors
• Auritec Pharmaceuticals
• Chimerix Pharmaceuticals
• Isis Pharmaceuticals
• pSivida
• Sanofi

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Global Cytomegalovirus Retinitis Market 2014-2018

• Market Driver
• Presence of Unmet Needs
• Market Challenge
• Lack of Approved Treatment Guidelines by the
  World Health Organization
• Market Trend
• Increase in Combination Therapies
• Key Questions Answered in this Report
• What will the market size be in 2018 and what
  will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats
  faced by the key vendors?
• What are the strengths and weaknesses of the key
  vendors?
• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/Discount.aspx?name295209.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.